Skip to main content
Erschienen in: Journal of Neurology 3/2024

13.01.2024 | Review

Associations between olfactory dysfunction and cognition: a scoping review

verfasst von: Patricia T. Jacobson, Brandon J. Vilarello, Jeremy P. Tervo, Nicholas A. Waring, David A. Gudis, Terry E. Goldberg, D. P. Devanand, Jonathan B. Overdevest

Erschienen in: Journal of Neurology | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Strong evidence suggests that olfactory dysfunction (OD) can predict additional neurocognitive decline in neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. However, research exploring olfaction and cognition in younger populations is limited. The aim of this review is to evaluate cognitive changes among non-elderly adults with non-COVID-19-related OD.

Methods

We performed a structured comprehensive literature search of PubMed, Ovid Embase, Web of Science, and Cochrane Library in developing this scoping review. The primary outcome of interest was the association between OD and cognitive functioning in adults less than 60 years of age.

Results

We identified 2878 studies for title and abstract review, with 167 undergoing full text review, and 54 selected for data extraction. Of these, 34 studies reported on populations of individuals restricted to the ages of 18–60, whereas the remaining 20 studies included a more heterogeneous population with the majority of individuals in this target age range in addition to some above the age of 60. The etiologies for smell loss among the included studies were neuropsychiatric disorders (37%), idiopathic cause (25%), type 2 diabetes (7%), trauma (5%), infection (4%), intellectual disability (4%), and other (18%). Some studies reported numerous associations and at times mixed, resulting in a total number of associations greater than the included number of 54 studies. Overall, 21/54 studies demonstrated a positive association between olfaction and cognition, 7/54 demonstrated no association, 25/54 reported mixed results, and only 1/54 demonstrated a negative association.

Conclusion

Most studies demonstrate a positive correlation between OD and cognition, but the data are mixed with associations less robust in this young adult population compared to elderly adults. Despite the heterogeneity in study populations and outcomes, this scoping review serves as a starting point for further investigation on this topic. Notably, as many studies in this review involved disorders that may have confounding effects on both olfaction and cognition, future research should control for these confounders and incorporate non-elderly individuals with non-psychiatric causes of smell loss.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nordin S, Brämerson A (2008) Complaints of olfactory disorders: epidemiology, assessment and clinical implications. Curr Opin Allergy Clin Immunol 8(1):10–15CrossRefPubMed Nordin S, Brämerson A (2008) Complaints of olfactory disorders: epidemiology, assessment and clinical implications. Curr Opin Allergy Clin Immunol 8(1):10–15CrossRefPubMed
6.
Zurück zum Zitat Sui X, Zhou C, Li J et al (2019) Hyposmia as a predictive marker of Parkinson’s disease: a systematic review and meta-analysis. Biomed Res Int 2019:1 Sui X, Zhou C, Li J et al (2019) Hyposmia as a predictive marker of Parkinson’s disease: a systematic review and meta-analysis. Biomed Res Int 2019:1
8.
Zurück zum Zitat Lafaille-Magnan M-E, Poirier J, Etienne P et al (2017) Odor identification as a biomarker of preclinical AD in older adults at risk From the Centre for Studies on Prevention of AD Lafaille-Magnan M-E, Poirier J, Etienne P et al (2017) Odor identification as a biomarker of preclinical AD in older adults at risk From the Centre for Studies on Prevention of AD
9.
Zurück zum Zitat Marin C, Vilas D, Langdon C et al (2018) Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep 18:1CrossRef Marin C, Vilas D, Langdon C et al (2018) Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep 18:1CrossRef
10.
Zurück zum Zitat Yan Y, Aierken A, Wang C et al (2022) A potential biomarker of preclinical Alzheimer’s disease: the olfactory dysfunction and its pathogenesis-based neural circuitry impairments. Neurosci Biobehav Rev 132:857–869CrossRefPubMed Yan Y, Aierken A, Wang C et al (2022) A potential biomarker of preclinical Alzheimer’s disease: the olfactory dysfunction and its pathogenesis-based neural circuitry impairments. Neurosci Biobehav Rev 132:857–869CrossRefPubMed
12.
Zurück zum Zitat Doty RL (2017) Olfactory dysfunction in neurodegenerative diseases: Is there a common pathological substrate? Lancet Neurol 16(6):478–488CrossRefPubMed Doty RL (2017) Olfactory dysfunction in neurodegenerative diseases: Is there a common pathological substrate? Lancet Neurol 16(6):478–488CrossRefPubMed
14.
Zurück zum Zitat Langa KM, Levine DA (2014) The diagnosis and management of mild cognitive impairment: a clinical review. JAMA J Am Med Assoc 312:2551–2561CrossRef Langa KM, Levine DA (2014) The diagnosis and management of mild cognitive impairment: a clinical review. JAMA J Am Med Assoc 312:2551–2561CrossRef
18.
Zurück zum Zitat Devanand D, Michaels-Marston KS, Xinhua Liu M et al (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 157:1399–1405CrossRefPubMed Devanand D, Michaels-Marston KS, Xinhua Liu M et al (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 157:1399–1405CrossRefPubMed
43.
Zurück zum Zitat Hernandez AK, Landis B, Altundag A et al (2023) Olfactory nomenclature: an orchestrated effort to clarify terms and definitions of dysosmia, anosmia, hyposmia, normosmia, hyperosmia, olfactory intolerance, parosmia, and phantosmia/olfactory hallucination. ORL J Otorhinolaryngol Relat Spec. https://doi.org/10.1159/000530211CrossRefPubMed Hernandez AK, Landis B, Altundag A et al (2023) Olfactory nomenclature: an orchestrated effort to clarify terms and definitions of dysosmia, anosmia, hyposmia, normosmia, hyperosmia, olfactory intolerance, parosmia, and phantosmia/olfactory hallucination. ORL J Otorhinolaryngol Relat Spec. https://​doi.​org/​10.​1159/​000530211CrossRefPubMed
69.
Zurück zum Zitat Del Valle RM, Hollander E, McCracken J et al (2016) A multi-center, observational study to explore the relationship between exploratory biomarkers and functional dimensions in adults with autistic spectrum disorders. Eur Neuropsychopharmacol 26:S193CrossRef Del Valle RM, Hollander E, McCracken J et al (2016) A multi-center, observational study to explore the relationship between exploratory biomarkers and functional dimensions in adults with autistic spectrum disorders. Eur Neuropsychopharmacol 26:S193CrossRef
79.
Zurück zum Zitat Arnold SE, Hyman BT, Van Hoesen GW et al (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia from the departments of neurology. Arch Gen Psychiatry 48:625–632CrossRefPubMed Arnold SE, Hyman BT, Van Hoesen GW et al (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia from the departments of neurology. Arch Gen Psychiatry 48:625–632CrossRefPubMed
84.
Zurück zum Zitat Damiano RF, Guedes BF, de Rocca CC et al (2022) Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci 272:139–154CrossRefPubMed Damiano RF, Guedes BF, de Rocca CC et al (2022) Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci 272:139–154CrossRefPubMed
85.
Zurück zum Zitat Walker KR, Tesco G (2013) Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front Aging Neurosci 5:1CrossRef Walker KR, Tesco G (2013) Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front Aging Neurosci 5:1CrossRef
91.
Zurück zum Zitat Vance DE, Del Bene VA, Kamath V et al (2023) Does olfactory training improve brain function and cognition? A systematic review. Neuropsychol Rev 2023:1 Vance DE, Del Bene VA, Kamath V et al (2023) Does olfactory training improve brain function and cognition? A systematic review. Neuropsychol Rev 2023:1
Metadaten
Titel
Associations between olfactory dysfunction and cognition: a scoping review
verfasst von
Patricia T. Jacobson
Brandon J. Vilarello
Jeremy P. Tervo
Nicholas A. Waring
David A. Gudis
Terry E. Goldberg
D. P. Devanand
Jonathan B. Overdevest
Publikationsdatum
13.01.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2024
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-023-12057-7

Weitere Artikel der Ausgabe 3/2024

Journal of Neurology 3/2024 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.